OR WAIT null SECS
February 19, 2021
The importance of thinking strategically about the infrastructure and foresight needed to scale up CGTs—not as treatments of last resort, but first choice
February 18, 2021
Lab development project features 9,000-square-foot expansion
February 10, 2021
Results address concerns surrounding bulk passive pharma packaging
February 06, 2021
$180M collaboration aims to introduce multiple vaccine candidates in 2022
February 05, 2021
Two-dose COVAXIN currently under EUA in India
Rating for packaging supplier highlights its commitment to sustainable practices and corporate social responsibility
February 02, 2021
In Phase III at the moment, mRNA dose will be produced at Bayer's Wuppertal, Germany facility
January 30, 2021
Production expected to begin in the second quarter
January 23, 2021
Boston-area location will be fully operational in Q4
January 22, 2021
Latest air cargo collaboration provides pandemic response support